Guru Gurushankar has been appointed as senior vice president and general manager for the healthcare and life sciences vertical at ColorTokens Inc., a global enterprise microsegmentation firm. Prior to this, Gurushankar held leadership roles at companies such as Philips, AWS Healthcare, and GE Healthcare. His role at the ColorTokens will focus on securing patient data.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
